The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis
3
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose Cell division cycle and apoptosis regulator 1 (CCAR1) plays a dynamic role in regulation of cell growth and apoptosis by serving as a cofactor of steroid/thyroid nuclear receptors, !- catenin, and p53 in a variety of cell types including different cancer cells. However, whether CCAR1 protein is overexpressed in hepatocellular carcinoma (HCC) and the prognostic significance of CCAR1 protein expression in HCC have not been reported. Materials and Methods In 167 HCC patients with long-term follow-up, CCAR1 protein expression was examined by immunohistochemistry. Results High CCAR1 protein expression was observed in 149 of the 167 HCC cases (89.2%) and showed significant correlation with microvascular invasion, intrahepatic metastasis, higher American Joint Committee on Cancer (AJCC) T stage, and early recurrence. High CCAR1 expression showed an unfavorable effect on recurrence-free survival (RFS) (p=0.002). In subgroup analysis, among patients with "-fetoprotein # 20 ng/mL (n=54) and patients with AJCC T stage 1 (n=62), significant differences in RFS were observed between high CCAR1 expression groups and low CCAR1 expression groups (p=0.015 and p=0.004, respectively). High CCAR1 expression tended to be an independent predictor of shorter RFS (p=0.054) and showed an unfavorable effect on overall survival (OS) (p=0.015). In subgroup analysis, among patients with "-fetoprotein # 20 ng/mL (n=54), significant difference in OS was observed between high CCAR1 expression group and low CCAR1 expression group (p=0.046). Conclusion CCAR1 protein could be a potential biomarker predicting RFS in HCC patients after curative hepatectomy. In addition, CCAR1 had prognostic values in HCC patients with normal serum "-fetoprotein levels or early stage HCC.
Abstract
Purpose Cell division cycle and apoptosis regulator 1 (CCAR1) plays a dynamic role in regulation of cell growth and apoptosis by serving as a cofactor of steroid/thyroid nuclear receptors, !- catenin, and p53 in a variety of cell types including different cancer cells. However, whether CCAR1 protein is overexpressed in hepatocellular carcinoma (HCC) and the prognostic significance of CCAR1 protein expression in HCC have not been reported. Materials and Methods In 167 HCC patients with long-term follow-up, CCAR1 protein expression was examined by immunohistochemistry. Results High CCAR1 protein expression was observed in 149 of the 167 HCC cases (89.2%) and showed significant correlation with microvascular invasion, intrahepatic metastasis, higher American Joint Committee on Cancer (AJCC) T stage, and early recurrence. High CCAR1 expression showed an unfavorable effect on recurrence-free survival (RFS) (p=0.002). In subgroup analysis, among patients with "-fetoprotein # 20 ng/mL (n=54) and patients with AJCC T stage 1 (n=62), significant differences in RFS were observed between high CCAR1 expression groups and low CCAR1 expression groups (p=0.015 and p=0.004, respectively). High CCAR1 expression tended to be an independent predictor of shorter RFS (p=0.054) and showed an unfavorable effect on overall survival (OS) (p=0.015). In subgroup analysis, among patients with "-fetoprotein # 20 ng/mL (n=54), significant difference in OS was observed between high CCAR1 expression group and low CCAR1 expression group (p=0.046). Conclusion CCAR1 protein could be a potential biomarker predicting RFS in HCC patients after curative hepatectomy. In addition, CCAR1 had prognostic values in HCC patients with normal serum "-fetoprotein levels or early stage HCC.
참고문헌 (20)
- El-Serag HB, "Hepatocellular carcinoma : epidemiology and molecular carcinogenesis", Gastroenterology, 132, pp.2557~2576 (2007)
- Llovet JM, "Resection and liver transplantation for hepatocellular carcinoma", Semin Liver Dis, 25, pp.181~200 (2005)
- Qin LX, "Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma : a review of the literature", J Cancer Res Clin Oncol, 130, pp.497~513 (2004)
- Rishi AK, "Identification and characterization of a cell cycle and apoptosis regulatory protein-1 as a novel mediator of apoptosis signaling by retinoid CD437", J Biol Chem, 278, pp.33422~33435 (2003)
- Rishi AK, "Cell cycle-and apoptosis-regulatory protein-1 is involved in apoptosis signaling by epidermal growth factor receptor", J Biol Chem, 281, pp.13188~13198 (2006)
- Jiang Y, "A novel mechanism of cell growth regulation by cell cycle and apoptosis regulatory protein(CARP)-1", J Mol Signal, 5, pp.7~ (2010)
- Kim JH, "CCAR1, a key regulator of mediator complex recruitment to nuclear receptor transcription complexes", Mol Cell, 31, pp.510~519 (2008)
- Seo WY, "CCAR1 promotes chromatin loading of androgen receptor (AR) transcription complex by stabilizing the association between AR and GATA2", Nucleic Acids Res, 41, pp.8526~8536 (2013)
- Ou CY, "Requirement of cell cycle and apoptosis regulator 1 for target gene activation by Wnt and beta-catenin and for anchorage-independent growth of human colon carcinoma cells", J Biol Chem, 284, pp.20629~20637 (2009)
- Edge SB, "AJCC cancer staging manual" (2010), Springe
- Llovet JM, "Prognosis of hepatocellular carcinoma : the BCLC staging classification", Semin Liver Dis, 19, pp.329~338 (1999)
- Kumada T, "Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma", Hepatology, 25, pp.87~92 (1997)
- Imamura H, "Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy", J Hepatol, 38, pp.200~207 (2003)
- 현지연, "CHD1L Is a Marker for Poor Prognosis of Hepatocellular Carcinoma after Surgical Resection", Journal of Pathology and Translational Medicine, 47(1), pp.9~15 (2013), 대한병리학회
- Hoshida Y, "Gene expression in fixed tissues and outcome in hepatocellular carcinoma", N Engl J Med, 359, pp.1995~2004 (2008)
- O'Grady JG, "Acute liver failure : redefining the syndromes", Lancet, 342, pp.273~275 (1993)
- Zhang L, "Transactivator of transcription-tagged cell cycle and apoptosis regulatory protein-1 peptides suppress the growth of human breast cancer cells in vitro and in vivo", Mol Cancer Ther, 6, pp.1661~1672 (2007)
- Puliyappadamba VT, "Antagonists of anaphase-promoting complex(APC)-2-cell cycle and apoptosis regulatory protein(CARP)-1 interaction are novel regulators of cell growth and apoptosis", J Biol Chem, 286, pp.38000~38017 (2011)
- Muthu M, "Identification and testing of novel CARP-1 functional mimetic compounds as inhibitors of non-small cell lung and triple-negative breast cancers", J Biomed Nanotechnol, 11, pp.1608~1627 (2015)
- Johnson PJ, "The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma", Clin Liver Dis, 5, pp.145~159 (2001)